The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Dermatologic side effects associated with the epidermal growth factor receptor inhibitors
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cunningham, D., Humblet, Y., Siena, S., Khayat, D., Bleiberg, H., Santoro, A., Bets, D., Mueser, M., Harstrick, A., Verslype, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033025 · Cited by 5,035
Giaccone, G., Herbst, R. S., Manegold, C., Scagliotti, G., Rosell, R., Miller, V., Natale, R. B., Schiller, J. H., von Pawel, J., Pluzanska, A., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.001 · Cited by 1,716
Herbst, R. S., Giaccone, G., Schiller, J. H., Natale, R. B., Miller, V., Manegold, C., Scagliotti, G., Rosell, R., Oliff, I., Reeves, J. A., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.215 · Cited by 1,707
Saltz, L. B., Meropol, N. J., Loehrer, P. J., Needle, M. N., Kopit, J., & Mayer, R. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.182 · Cited by 1,694
Lever's Histopathology of the Skin
Ackerman, A. B. (1998) · Archives of Dermatology · doi:10.1001/archderm.134.2.251 · Cited by 1,074
Pérez-Soler, R., Chachoua, A., Hammond, L. A., Rowinsky, E. K., Huberman, M., Karp, D., Rigas, J., Clark, G. M., Santabárbara, P., & Bonomi, P. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.057 · Cited by 1,070
Hidalgo, M., Siu, L. L., Nemunaitis, J., Rizzo, J., Hammond, L. A., Takimoto, C., Eckhardt, S. G., Tolcher, A., Britten, C. D., Denis, L., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.13.3267 · Cited by 1,001
Lever's Histopathology of the Skin
Elder, D. E. (1999) · Cited by 874
Baselga, J., Rischin, D., Ranson, M., Calvert, H., Raymond, E., Kieback, D. G., Kaye, S. B., Gianni, L., Harris, A., Bjork, T., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.03.100 · Cited by 829
Soulieres, D., Senzer, N. N., Vokes, E. E., Hidalgo, M., Agarwala, S. S., & Siu, L. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.075 · Cited by 807
Ranson, M., Hammond, L. A., Ferry, D., Kris, M., Tullo, A., Murray, P. I., Miller, V., Averbuch, S., Ochs, J., Morris, C., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.112 · Cited by 763
Phase II Trial of ZD1839 in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Cohen, E. E. W., Rosen, F., Stadler, W. M., Recant, W., Stenson, K., Huo, D., & Vokes, E. E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.051 · Cited by 610
Herbst, R. S., Maddox, A.-M., Rothenberg, M. L., Small, E. J., Rubin, E. H., Baselga, J., Rojo, F., Hong, W. K., Swaisland, H., Averbuch, S. D., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.03.038 · Cited by 572
Cutaneous side-effects of kinase inhibitors and blocking antibodies
Robert, C., Soria, J.-C., Spatz, A., Le Cesne, A., Malka, D., Pautier, P., Wechsler, J., Lhomme, C., Escudier, B., Boige, V., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70243-6 · Cited by 554
Albanell, J., Rojo, F., Averbuch, S., Feyereislova, A., Mascaro, J. M., Herbst, R. S., LoRusso, P. M., Rischin, D., Sauleda, S., Gee, J., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.110 · Cited by 528
Busam, K. J., Capodieci, P., Motzer, R., Kiehn, T., Phelan, D., & Halpern, A. C. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04226.x · Cited by 419
Self-citationRowinsky, E. K., Schwartz, G. H., Gollob, J. A., Thompson, J. A., Vogelzang, N. J., Figlin, R., Bukowski, R., Haas, N., Lockbaum, P., Li, Y.-P., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.061 · Cited by 329
The EGF receptor - an essential regulator of multiple epidermal functions.
Jost, M., Kari, C., & Rodeck, U. (2000) · PubMed · Cited by 302
Crombet, T., Osorio, M., Cruz, T., Roca, C., del Castillo, R., Mon, R., Iznaga-Escobar, N., Figueredo, R., Koropatnick, J., Renginfo, E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.089 · Cited by 296
Targeted Therapies for Cancer 2004
Ross, J. S., Schenkein, D. P., Pietrusko, R. G., Rolfe, M., Linette, G. P., Stec, J. J., Stagliano, N. E., Ginsburg, G. S., Symmans, W. F., Pusztai, L., et al. (2004) · American Journal of Clinical Pathology · doi:10.1309/5cwp-u41a-fr1v-ym3f · Cited by 286
Pérez-Soler, R., Delord, J. P., Halpern, A., Kelly, K., Krueger, J., Sureda, B. M., von Pawel, J., Temel, J., Siena, S., Soulières, D., et al. (2005) · The Oncologist · doi:10.1634/theoncologist.10-5-345 · Cited by 275
Self-citationVanhoefer, U., Tewes, M., Rojo, F., Dirsch, O., Schleucher, N., Rosen, O., Tillner, J., Kovar, A., Braun, A. H., Trarbach, T., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.114 · Cited by 261
Murillas, R., Larcher, F., Conti, C. J., Santos, M., Ullrich, A., & Jorcano, J. L. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00206.x · Cited by 249
Practical Management of Patients With Non–Small-Cell Lung Cancer Treated With Gefitinib
Shah, N. T., Kris, M. G., Pao, W., Tyson, L. B., Pizzo, B. M., Heinemann, M.-H., Ben-Porat, L., Sachs, D. L., Heelan, R. T., & Miller, V. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.057 · Cited by 191
Distribution and function of EGFR in human tissue and the effect of EGFR tyrosine kinase inhibition.
Yano, S., Kondo, K., Yamaguchi, M., Richmond, G. H. P., Hutchison, M., Wakeling, A. E., Averbuch, S. D., & Wadsworth, P. F. (2004) · PubMed · Cited by 178
Rowinsky, E. K. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.104433 · Cited by 178
Motzer, R. J., Amato, R. J., Todd, M. B., Poo, W.-J., Cohen, R. B., Baselga, J. M., Muss, H. B., Cooper, M. R., Yu, R., Ginsberg, M. S., et al. (2003) · Investigational New Drugs · doi:10.1023/a:1022928612511 · Cited by 154
Can rash associated with HER1/EGFR inhibition be used as a marker of treatment outcome?
Perez-Soler, R. (2003) · PubMed · Cited by 150
Bence, A. K., Anderson, E. B., Halepota, M. A., Doukas, M. A., DeSimone, P. A., Davis, G. A., Smith, D. A., Koch, K. M., Stead, A. G., Mangum, S., et al. (2004) · Investigational New Drugs · doi:10.1023/b:drug.0000047104.45929.ea · Cited by 122
Dermatologic Side Effects Associated with Gefitinib Therapy: Clinical Experience and Management
Herbst, R. S., LoRusso, P. M., Purdom, M., & Ward, D. A. (2003) · Clinical Lung Cancer · doi:10.3816/clc.2003.n.016 · Cited by 119
Epidermal Growth Factor Receptor Inhibition Induces Trichomegaly
Dueland, S., Sauer, T., Lund‐Johansen, F., Østenstad, B., & Tveit, K. M. (2003) · Acta Oncologica · doi:10.1080/02841860310006038 · Cited by 108
Mohamed, M. K., Ramalingam, S. S., Lin, Y., Gooding, W. E., & Belani, C. P. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi157 · Cited by 93
Kimyai‐Asadi, A., & Jih, M. H. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.1.129 · Cited by 89
Calvo, E., Tolcher, A. W., Hammond, L. A., Patnaik, A., Bono, J. S. D., Eiseman, I. A., Olson, S. C., Lenehan, P. F., McCreery, H., LoRusso, P. M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1187 · Cited by 81
Park, J., Park, B. B., Kim, J. Y., Lee, S., Lee, S. I., Kim, H. Y., Kim, J. H., Park, S. H., Lee, K.-E., Park, J. O., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0189 · Cited by 79
A safety, tolerability, and pharmacokinetic (PK) study of GW572016 in patients with solid tumors
Pandite, L. N., Burris, H. A., Jones, S. F., Wilding, G., Taylor, C., Versola, M., Smith, D. A., Stead, A. G., Koch, K. M., & Spector, N. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.14_suppl.3179 · Cited by 18
Dees, E. C., Burris, H. A., Hurwitz, H. I., Dowlati, A., Smith, D. A., Koch, K., Stead, A. G., Mangum, S., Harris, J., & Spector, N. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.90140.3188 · Cited by 15
Cited by
CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity
Choi, B. D., Yu, X., Castano, A. P., Bouffard, A. A., Schmidts, A., Larson, R. C., Bailey, S. R., Boroughs, A. C., Frigault, M. J., Leick, M. B., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0192-1 · Cited by 571
The Epidermal Growth Factor Receptor System in Skin Repair and Inflammation
Pastore, S., Mascia, F., Mariani, V., & Girolomoni, G. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701184 · Cited by 443
Lynch, T. J., Kim, E. S., Eaby, B., Garey, J., West, D. P., & Lacouture, M. E. (2007) · The Oncologist · doi:10.1634/theoncologist.12-5-610 · Cited by 341
Understanding, recognizing, and managing toxicities of targeted anticancer therapies
Dy, G. K., & Adjei, A. A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21184 · Cited by 331
Review: Side Effects of Approved Molecular Targeted Therapies in Solid Cancers
Widakowich, C., de Castro, G., de Azambuja, E., Dinh, P., & Awada, A. (2007) · The Oncologist · doi:10.1634/theoncologist.12-12-1443 · Cited by 324
Metadata
- Authors
- Agero, A. L. C., Dusza, S. W., Benvenuto-Andrade, C., Busam, K. J., Myskowski, P., & Halpern, A. C.
- Venue
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Published
- 2006-10
- Volume
- 55
- Issue
- 4
- Pages
- 657-670
- ISSN
- 0190-9622 (ISSN-L)
- OpenAlex
- W1998085563
- Cited by
- 381
- References
- 37
- FWCI
- 29.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.